Toward a more accurate estimate of the prevalence of hepatitis C in the United States
- PMID: 26171595
- PMCID: PMC4751870
- DOI: 10.1002/hep.27978
Toward a more accurate estimate of the prevalence of hepatitis C in the United States
Abstract
Data from the 2003-2010 National Health and Nutrition Examination Survey (NHANES) indicate that about 3.6 million people in the United States have antibodies to the hepatitis C virus, of whom 2.7 million are currently infected. NHANES, however, excludes several high-risk populations from its sampling frame, including people who are incarcerated, homeless, or hospitalized; nursing home residents; active-duty military personnel; and people living on Indian reservations. We undertook a systematic review of peer-reviewed literature and sought out unpublished presentations and data to estimate the prevalence of hepatitis C in these excluded populations and in turn improve the estimate of the number of people with hepatitis C in the United States. The available data do not support a precise result, but we estimated that 1.0 million (range 0.4 million-1.8 million) persons excluded from the NHANES sampling frame have hepatitis C virus antibody, including 500,000 incarcerated people, 220,000 homeless people, 120,000 people living on Indian reservations, and 75,000 people in hospitals. Most are men. An estimated 0.8 million (range 0.3 million-1.5 million) are currently infected. Several additional sources of underestimation, including nonresponse bias and the underrepresentation of other groups at increased risk of hepatitis C that are not excluded from the NHANES sampling frame, were not addressed in this study.
Conclusion: The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million (range 3.4 million-6.0 million), and of these, at least 3.5 million (range 2.5 million-4.7 million) are currently infected; additional sources of potential underestimation suggest that the true prevalence could well be higher.
© 2015 by the American Association for the Study of Liver Diseases.
Comment in
-
Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States.Hepatology. 2015 Nov;62(5):1339-41. doi: 10.1002/hep.28026. Epub 2015 Sep 29. Hepatology. 2015. PMID: 26239816 Free PMC article. No abstract available.
Similar articles
-
Hepatitis C virus infection in USA: an estimate of true prevalence.Liver Int. 2011 Sep;31(8):1090-101. doi: 10.1111/j.1478-3231.2011.02494.x. Epub 2011 Mar 16. Liver Int. 2011. PMID: 21745274 Review.
-
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6. Hepatology. 2019. PMID: 30398671 Free PMC article. Review.
-
The burden of hepatitis C in the United States.Hepatology. 2002 Nov;36(5 Suppl 1):S30-4. doi: 10.1053/jhep.2002.36791. Hepatology. 2002. PMID: 12407574 Review.
-
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.J Hepatol. 2014 Apr;60(4):691-8. doi: 10.1016/j.jhep.2013.11.014. Epub 2013 Nov 27. J Hepatol. 2014. PMID: 24291324
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.N Engl J Med. 1999 Aug 19;341(8):556-62. doi: 10.1056/NEJM199908193410802. N Engl J Med. 1999. PMID: 10451460
Cited by
-
A dynamic model and some strategies on how to prevent and control hepatitis c in mainland China.BMC Infect Dis. 2019 Aug 16;19(1):724. doi: 10.1186/s12879-019-4311-x. BMC Infect Dis. 2019. PMID: 31420017 Free PMC article.
-
Successful Implementation of a Shared Medical Appointment Model for Hepatitis C Treatment at a Community Health Center.J Community Health. 2019 Feb;44(1):169-171. doi: 10.1007/s10900-018-0568-z. J Community Health. 2019. PMID: 30132236 Free PMC article.
-
Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system.J Viral Hepat. 2018 Nov;25(11):1270-1279. doi: 10.1111/jvh.12937. Epub 2018 Jul 3. J Viral Hepat. 2018. PMID: 29851265 Free PMC article.
-
Retrospective Study Demonstrating High Rates of Sustained Virologic Response After Treatment With Direct-Acting Antivirals Among American Indian/Alaskan Natives.Open Forum Infect Dis. 2019 Jul 4;6(7):ofz128. doi: 10.1093/ofid/ofz128. eCollection 2019 Jul. Open Forum Infect Dis. 2019. PMID: 31289725 Free PMC article.
-
What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?J Interferon Cytokine Res. 2019 Oct;39(10):618-626. doi: 10.1089/jir.2019.0048. Epub 2019 Jun 4. J Interferon Cytokine Res. 2019. PMID: 31161939 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention [September 22, 2014];National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm.
-
- Zipf G, Porter KS, Ostchega Y, Lewis BG, Dostal J. National Health and Nutrition Examination Survey: Plan and operations, 1999-2010. National Center for Health Statistics. Vital Health Stat. 2013;1(56):1–28. http://www.cdc.gov/nchs/data/series/sr_01/sr01_056.pdf. - PubMed
-
- McQuillan GM, Khare M, Karon JM, Schable CA, Vlahov D. Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:355–360. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical